Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction-Reference-Cited by-同舟云学术

Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction

Published:2021-10 Issue: Volume:139 Page:106066
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Collado Aida,Domingo Elena,Piqueras Laura,Sanz Maria-Jesus

Funder

Generalitat Valenciana

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

European Regional Development Fund

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference63 articles.

1. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities;Back;Nature Rev. Cardiol.,2019

2. Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up;Barale;Nutr Metab Cardiovasc Dis.,2020

3. Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia;Barale;Biomed Res Int.,2018

4. Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells;Basuroy;Am. J. Physiol. Cell Physiol,2009

5. TNF and ROS crosstalk in inflammation;Blaser;Trends Cell. Biol.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vitro Antioxidant and Hypocholesterolemic Potency of Melon (Cucumis melo L.) Seed Protein Hydrolysate;Current Research in Nutrition and Food Science Journal;2024-08-30

2. Serum metabolites and hypercholesterolemia: insights from a two-sample Mendelian randomization study;Frontiers in Cardiovascular Medicine;2024-07-25

3. Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective;Current Atherosclerosis Reports;2024-05-30

4. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?;Pharmacological Research;2024-02

5. Chlorogenic acid regulates the expression of NPC1L1 and HMGCR through PXR and SREBP2 signaling pathways and their interactions with HSP90 to maintain cholesterol homeostasis;Phytomedicine;2024-01